STXSStereotaxis, Inc.

NYSE stereotaxis.com


$ 2.09 $ 0.00 (0 %)    

Wednesday, 15-May-2024 15:59:53 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 2.09
$ 2.14
$ 0.00 x 0
$ 2.09 x 400
$ 2.08 - $ 2.16
$ 1.33 - $ 3.29
449,699
na
174.47M
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-15-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-20-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-10-2016 06-30-2016 10-Q
33 05-11-2016 03-31-2016 10-Q
34 03-11-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-16-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stereotaxis-invited-by-africa-heart-rhythm-association-to-present-its-robotic-solution-to-expand-high-quality-therapy-in-africa

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

 stereotaxis-q1-2024-gaap-eps-006-inline-sales-6880m-miss-7000m-estimate

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 14.2...

 lake-street-maintains-buy-on-stereotaxis-raises-price-target-to-4

Lake Street analyst Frank Takkinen maintains Stereotaxis (AMEX:STXS) with a Buy and raises the price target from $3 to $4.

 roth-mkm-reiterates-buy-on-stereotaxis-maintains-5-price-target

Roth MKM analyst Jason Wittes reiterates Stereotaxis (AMEX:STXS) with a Buy and maintains $5 price target.

 recap-stereotaxis-q4-earnings
Recap: Stereotaxis Q4 Earnings
03/04/2024 21:10:11

 stereotaxis-q4-2023-gaap-eps-0070-inline-sales-4565m-miss-7700m-estimate

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.070) per share which met the analyst consensus estimate. The company ...

 earnings-scheduled-for-march-4-2024

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

 earnings-preview-for-stereotaxis
Earnings Preview For Stereotaxis
03/01/2024 15:01:36

 roth-mkm-initiates-coverage-on-stereotaxis-with-buy-rating-announces-price-target-of-5

Roth MKM analyst Jason Wittes initiates coverage on Stereotaxis (AMEX:STXS) with a Buy rating and announces Price Target of $5.

 insiders-buying-eyenovia-and-3-other-stocks-under-2

The Dow Jones closed lower by around 80 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence...

 recap-stereotaxis-q3-earnings
Recap: Stereotaxis Q3 Earnings
11/09/2023 14:15:06

 stereotaxis-q3-eps-007-misses-006-estimate-sales-780m-miss-828m-estimate

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION